Published in J Mater Chem B Mater Biol Med on September 18, 2015
Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials. Adv Mater (2016) 0.75
Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies. Adv Healthc Mater (2016) 0.75
Programmable biomaterials for dynamic and responsive drug delivery. Exp Biol Med (Maywood) (2016) 0.75
Evolution of hierarchical porous structures in supramolecular guest-host hydrogels. Soft Matter (2016) 0.75
Enhanced User-Control of Small Molecule Drug Release from a Poly(ethylene glycol) Hydrogel via Azobenzene/Cyclodextrin Complex Tethers. J Mater Chem B Mater Biol Med (2016) 0.75
Shear-thinning and self-healing hydrogels as injectable therapeutics and for 3D-printing. Nat Protoc (2017) 0.75
Theoretical analysis of fluorescence photobleaching recovery experiments. Biophys J (1983) 4.70
Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov (2006) 4.39
Complexation Thermodynamics of Cyclodextrins. Chem Rev (1998) 3.60
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res (1998) 3.01
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol (2012) 2.91
Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat Mater (2013) 2.84
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood (2004) 2.84
Hyaluronic acid hydrogels for biomedical applications. Adv Mater (2011) 2.51
Matrix metalloproteinases as valid clinical targets. Curr Pharm Des (2007) 1.76
Two-component protein-engineered physical hydrogels for cell encapsulation. Proc Natl Acad Sci U S A (2009) 1.63
Biomedical importance of indoles. Molecules (2013) 1.53
Photoswitchable gel assembly based on molecular recognition. Nat Commun (2012) 1.48
Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol (2010) 1.44
Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem (2003) 1.35
Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery. Biomaterials (2006) 1.26
Supramolecular cross-linked networks via host-guest complexation with cucurbit[8]uril. J Am Chem Soc (2010) 1.26
Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals. Nat Chem (2012) 1.23
Yielding Behavior in Injectable Hydrogels from Telechelic Proteins. Macromolecules (2010) 1.21
Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. Biomaterials (2011) 1.18
Ultrahigh-water-content supramolecular hydrogels exhibiting multistimuli responsiveness. J Am Chem Soc (2012) 1.13
Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. Biomacromolecules (2013) 1.09
Sustained release of proteins from high water content supramolecular polymer hydrogels. Biomaterials (2012) 0.99
Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics. J Control Release (2009) 0.99
Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier. Biomacromolecules (2009) 0.97
Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials (2009) 0.96
Cyclodextrin complexation for affinity-based antibiotic delivery. Macromol Biosci (2010) 0.93
Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng (2006) 0.89
Self-healing gels based on constitutional dynamic chemistry and their potential applications. Chem Soc Rev (2014) 0.85
Tunable diblock copolypeptide hydrogel depots for local delivery of hydrophobic molecules in healthy and injured central nervous system. Biomaterials (2013) 0.84
Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels. Tissue Eng Part A (2014) 0.81
Avidity-controlled hydrogels for injectable co-delivery of induced pluripotent stem cell-derived endothelial cells and growth factors. J Control Release (2014) 0.81
Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. Acta Biomater (2009) 0.81
Pharmacokinetic study of an injectable long-acting parenteral formulation of doxycycline hyclate in calves. Res Vet Sci (2007) 0.79
Mathematical model accurately predicts protein release from an affinity-based delivery system. J Control Release (2014) 0.78
Structural and thermodynamic characterization of doxycycline/β-cyclodextrin supramolecular complex and its bacterial membrane interactions. Colloids Surf B Biointerfaces (2014) 0.77